Oral contraceptives and risk of gestational trophoblastic disease

Fabio Parazzini, Sonia Cipriani, Giorgia Mangili, Elena Garavaglia, Paolo Guarnerio, Elena Ricci, Guido Benzi, Barbara Salerio, Giampiero Polverino, Carlo La Vecchia

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Clinical reports suggested that the use of oral contraceptives (OC) after a molar pregnancy may increase the risk of persistent throphoblastic disease. However, few epidemiologic studies have analyzed the effect of OC use on the risk of developing gestational trophoblastic disease (GTD). To give further information, we have analyzed data from a case-control study on risk factors for GTD. Cases were 268 women with a histologically confirmed diagnosis of complete or partial mole referred to the participating Trophoblastic Disease Centers. A total of 268 subjects were interviewed; 79 cases were classified as partial and 159 as complete mole. Controls were randomly selected women who gave birth to healthy infants at term on randomly selected days in the same network of hospitals in which cases had been identified. A total of 104 cases and 130 controls reported ever OC use, and the corresponding odds ratio (OR) was 1.5 (95% CI, 1.1-2.1). The risk of GTD increases with duration of OC use: the OR was 1.7 (95% CI 1.2-2.6) for ever-users reporting ≥12 months of use. No consistent pattern of risk was observed with time since last OC use. We have analyzed separately the association between OC use and risk of complete and partial moles: no statistically significant difference emerged, but the OR for partial moles was higher (OR 3.0, 95% CI 1.6-8.4) than for complete mole (OR 1.0, 95% CI 1.8). In conclusion, we observed a weak association between OC use and GTD; such a weak association could be explained by factors other than causality.

Original languageEnglish
Pages (from-to)425-427
Number of pages3
JournalContraception
Volume65
Issue number6
DOIs
Publication statusPublished - 2002

Fingerprint

Gestational Trophoblastic Disease
Oral Contraceptives
Odds Ratio
Hydatidiform Mole
Causality
Case-Control Studies
Epidemiologic Studies
Parturition

Keywords

  • Oral contraceptive
  • Risk factors
  • Trophoblastic disease

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Cite this

Parazzini, F., Cipriani, S., Mangili, G., Garavaglia, E., Guarnerio, P., Ricci, E., ... La Vecchia, C. (2002). Oral contraceptives and risk of gestational trophoblastic disease. Contraception, 65(6), 425-427. https://doi.org/10.1016/S0010-7824(02)00293-7

Oral contraceptives and risk of gestational trophoblastic disease. / Parazzini, Fabio; Cipriani, Sonia; Mangili, Giorgia; Garavaglia, Elena; Guarnerio, Paolo; Ricci, Elena; Benzi, Guido; Salerio, Barbara; Polverino, Giampiero; La Vecchia, Carlo.

In: Contraception, Vol. 65, No. 6, 2002, p. 425-427.

Research output: Contribution to journalArticle

Parazzini, F, Cipriani, S, Mangili, G, Garavaglia, E, Guarnerio, P, Ricci, E, Benzi, G, Salerio, B, Polverino, G & La Vecchia, C 2002, 'Oral contraceptives and risk of gestational trophoblastic disease', Contraception, vol. 65, no. 6, pp. 425-427. https://doi.org/10.1016/S0010-7824(02)00293-7
Parazzini, Fabio ; Cipriani, Sonia ; Mangili, Giorgia ; Garavaglia, Elena ; Guarnerio, Paolo ; Ricci, Elena ; Benzi, Guido ; Salerio, Barbara ; Polverino, Giampiero ; La Vecchia, Carlo. / Oral contraceptives and risk of gestational trophoblastic disease. In: Contraception. 2002 ; Vol. 65, No. 6. pp. 425-427.
@article{1fc0e5d55e2c4eccb148ca568f3d545d,
title = "Oral contraceptives and risk of gestational trophoblastic disease",
abstract = "Clinical reports suggested that the use of oral contraceptives (OC) after a molar pregnancy may increase the risk of persistent throphoblastic disease. However, few epidemiologic studies have analyzed the effect of OC use on the risk of developing gestational trophoblastic disease (GTD). To give further information, we have analyzed data from a case-control study on risk factors for GTD. Cases were 268 women with a histologically confirmed diagnosis of complete or partial mole referred to the participating Trophoblastic Disease Centers. A total of 268 subjects were interviewed; 79 cases were classified as partial and 159 as complete mole. Controls were randomly selected women who gave birth to healthy infants at term on randomly selected days in the same network of hospitals in which cases had been identified. A total of 104 cases and 130 controls reported ever OC use, and the corresponding odds ratio (OR) was 1.5 (95{\%} CI, 1.1-2.1). The risk of GTD increases with duration of OC use: the OR was 1.7 (95{\%} CI 1.2-2.6) for ever-users reporting ≥12 months of use. No consistent pattern of risk was observed with time since last OC use. We have analyzed separately the association between OC use and risk of complete and partial moles: no statistically significant difference emerged, but the OR for partial moles was higher (OR 3.0, 95{\%} CI 1.6-8.4) than for complete mole (OR 1.0, 95{\%} CI 1.8). In conclusion, we observed a weak association between OC use and GTD; such a weak association could be explained by factors other than causality.",
keywords = "Oral contraceptive, Risk factors, Trophoblastic disease",
author = "Fabio Parazzini and Sonia Cipriani and Giorgia Mangili and Elena Garavaglia and Paolo Guarnerio and Elena Ricci and Guido Benzi and Barbara Salerio and Giampiero Polverino and {La Vecchia}, Carlo",
year = "2002",
doi = "10.1016/S0010-7824(02)00293-7",
language = "English",
volume = "65",
pages = "425--427",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Oral contraceptives and risk of gestational trophoblastic disease

AU - Parazzini, Fabio

AU - Cipriani, Sonia

AU - Mangili, Giorgia

AU - Garavaglia, Elena

AU - Guarnerio, Paolo

AU - Ricci, Elena

AU - Benzi, Guido

AU - Salerio, Barbara

AU - Polverino, Giampiero

AU - La Vecchia, Carlo

PY - 2002

Y1 - 2002

N2 - Clinical reports suggested that the use of oral contraceptives (OC) after a molar pregnancy may increase the risk of persistent throphoblastic disease. However, few epidemiologic studies have analyzed the effect of OC use on the risk of developing gestational trophoblastic disease (GTD). To give further information, we have analyzed data from a case-control study on risk factors for GTD. Cases were 268 women with a histologically confirmed diagnosis of complete or partial mole referred to the participating Trophoblastic Disease Centers. A total of 268 subjects were interviewed; 79 cases were classified as partial and 159 as complete mole. Controls were randomly selected women who gave birth to healthy infants at term on randomly selected days in the same network of hospitals in which cases had been identified. A total of 104 cases and 130 controls reported ever OC use, and the corresponding odds ratio (OR) was 1.5 (95% CI, 1.1-2.1). The risk of GTD increases with duration of OC use: the OR was 1.7 (95% CI 1.2-2.6) for ever-users reporting ≥12 months of use. No consistent pattern of risk was observed with time since last OC use. We have analyzed separately the association between OC use and risk of complete and partial moles: no statistically significant difference emerged, but the OR for partial moles was higher (OR 3.0, 95% CI 1.6-8.4) than for complete mole (OR 1.0, 95% CI 1.8). In conclusion, we observed a weak association between OC use and GTD; such a weak association could be explained by factors other than causality.

AB - Clinical reports suggested that the use of oral contraceptives (OC) after a molar pregnancy may increase the risk of persistent throphoblastic disease. However, few epidemiologic studies have analyzed the effect of OC use on the risk of developing gestational trophoblastic disease (GTD). To give further information, we have analyzed data from a case-control study on risk factors for GTD. Cases were 268 women with a histologically confirmed diagnosis of complete or partial mole referred to the participating Trophoblastic Disease Centers. A total of 268 subjects were interviewed; 79 cases were classified as partial and 159 as complete mole. Controls were randomly selected women who gave birth to healthy infants at term on randomly selected days in the same network of hospitals in which cases had been identified. A total of 104 cases and 130 controls reported ever OC use, and the corresponding odds ratio (OR) was 1.5 (95% CI, 1.1-2.1). The risk of GTD increases with duration of OC use: the OR was 1.7 (95% CI 1.2-2.6) for ever-users reporting ≥12 months of use. No consistent pattern of risk was observed with time since last OC use. We have analyzed separately the association between OC use and risk of complete and partial moles: no statistically significant difference emerged, but the OR for partial moles was higher (OR 3.0, 95% CI 1.6-8.4) than for complete mole (OR 1.0, 95% CI 1.8). In conclusion, we observed a weak association between OC use and GTD; such a weak association could be explained by factors other than causality.

KW - Oral contraceptive

KW - Risk factors

KW - Trophoblastic disease

UR - http://www.scopus.com/inward/record.url?scp=0035991049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035991049&partnerID=8YFLogxK

U2 - 10.1016/S0010-7824(02)00293-7

DO - 10.1016/S0010-7824(02)00293-7

M3 - Article

C2 - 12127642

AN - SCOPUS:0035991049

VL - 65

SP - 425

EP - 427

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 6

ER -